1-877-534-3371

LEHDER News

Notice of Intent Issued to Apply the Significant New Activity Provisions Under CEPA to 54 Substances

     Posted by LEHDER News on

CEPA Notice of IntentA Notice of Intent proposing the application of the SNAc provisions of the Canadian Environmental Protection Act, 1999 (CEPA) to 54 substances, was published in the Canada Gazette, Part I, on December 3, 2016. The names and CAS Registry Numbers of these 54 substances are listed in Annex 1 of the Notice of Intent and are also provided in the table below.

The final screening assessments collectively conclude that 729 substances are not entering the environment in a quantity or concentration or under conditions that constitute a danger to human health or the environment and, therefore, do not meet any of the criteria set out in section 64 of CEPA. Fifty-four of the 729 substances were further identified as having properties or effects of concern.

Since the 54 substances are recognized as having potential human health or ecological effects of concern, there is suspicion that new activities that have not been identified or assessed could lead to these substances meeting the criteria set out in section 64 of CEPA. Therefore, the Government is proposing to amend the DSL, under subsection 87(3) of the Act, to indicate that the SNAc provisions under subsection 81(3) of the Act apply with respect to the 54 substances.

A significant new activity can include an activity that is not currently occurring or an existing activity involving a different quantity or occurring in different circumstances that could affect the exposure pattern of the substance. The SNAc provisions trigger an obligation for a person (individual or corporation) to provide, and for the Government to assess, specific information when a person proposes to use the substance in a significant new activity. The provisions are used to assess the risks associated with the proposed new activity before the new activity is undertaken. The Minister of Environment and Climate Change and the Minister of Health assess the information provided by the notifier and other information available to them to determine whether the substance, if used in the proposed new activity, could pose a risk to the environment or human health, and if so, whether risk management is required.

Information gathering methods other than the use of the SNAc provisions were considered, including the addition of the substances to the list of substances subject to the Inventory Update under CEPA, and the periodic market surveillance of products through the analysis of Safety Data Sheets (SDS). However, these tools would collect information after the substance may have been used. This could potentially lead to exposure sources of concern.

Notice of Intent - Comment Period Open

Within 60 days of publication of the Notice of Intent for these 54 substances, any person may submit comments to the Minister of Environment and Climate Change Canada with respect to the proposal.

Please provide any information on activities that you have not already provided to the program. The information will help inform decisions with respect to the potential application of the SNAc provisions to the substance(s). Comments will be, to the extent possible, taken into consideration during the development of the Order amending the DSL to apply the SNAc provisions to these substances. The Order will be published in the Canada Gazette, Part II. You will be notified of this publication in the coming months.

In accordance with section 313 of CEPA, any person who provides information may submit, with the information, a request that it be treated as confidential.

All comments must cite the Canada Gazette, Part I, and the date of publication of the notice and be sent to the following address:

Mailing address:
Executive Director, Program Development and Engagement Division
Environment and Climate Change Canada
Ottawa, ON  K1A 0H3
 
Delivery by messenger:
Executive Director, Program Development and Engagement Division
Environment and Climate Change Canada
171 Jean-Proulx Street.
Gatineau, QC J8Z 1W5

Email address:

eccc.substances.eccc@canada.ca

For more information, please visit:

  • the Chemicals Substances Web site:

http://www.chemicalsubstanceschimiques.gc.ca/plan/index-eng.php

  • the SNAc provisions under CEPA Web site:

http://www.ec.gc.ca/lcpe-cepa/default.asp?Lang=En&n=9EFCCB36-1

  • the comprehensive listing of substances that are subject to the SNAc provisions:

http://www.ec.gc.ca/subsnouvelles-newsubs/default.asp?lang=En&n=0F76206A-

 

For any question please contact the Substances Management  Information Line:
Telephone: 1-800-567-1999 (in Canada) or 819-938-3232
Fax: 819-938-5212
Email: eccc.substances.eccc@canada.ca  


Annex 1: List of 54 substances for which SNAc provisions are proposed to be applied.

Substance Name

CAS RN

Substances identified for tracking from Rapid Screening assessment following Phase One of the DSL IU

Benzenamine, 2,6-dimethyl-

87-62-7

Urea, N’-(4-chlorophenyl)-N,N-dimethyl-

150-68-5

Arsonium, tetraphenyl-, chloride

507-28-8

Hexanoic acid, 2-ethyl-, nickel(2++) salt

4454-16-4

Octanoic acid, nickel(2++) salt 

4995-91-9

Hexanoic acid, 2-ethyl-, nickel salt

7580-31-6

1,2-Ethanediamine, N-(1,3-dimethylbutylidene)-N’-[2-[(1,3-dimethylbutylidene)amino]ethyl]-

10595-60-5

Cadmium, bis(diethylcarbamodithioato-S,S’)-, (T-4)-

14239-68-0

Methanaminium, N-[4-[[4-(dimethylamino)phenyl]phenylmethylene]-2,5-cyclohexadien-1-ylidene]-N-methyl-, ethanedioate

18015-76-4

Benzenamine, 4,4’-methylenebis[2-ethyl- /

19900-65-3

Benzene, 1,1’,1’’-(chloromethylidyne)tris[4-methoxy-

49757-42-8

1,3,5-Triazine-2,4,6(1H,3H,5H)-trione, 1,3,5-tris(2,3-dibromopropyl)- 

52434-90-9

Disiloxane, 1,3-dichloro-1,1,3,3-tetrakis(1-methylethyl)- 

69304-37-6

Arsonium, tetraphenyl-, chloride, compd. with hydrochloric acid (1:1) 

73003-83-5

Benzene, trimethylbis(phenylmethyl)- 

114792-68-6

Substances identified for tracking from Rapid Screening assessment following Phase Two of the DSL IU

L-Tyrosine, O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-

51-48-9

Benzene, nitro-

98-95-3

Carbamic acid, (methylenedi-4,1-phenylene)bis-, diphenyl ester

101-65-5

Oxacycloheptadec-8-en-2-one, (Z)-

123-69-3

2-Naphthalenamine, N-phenyl-

135-88-6

Acetic acid, trichloro-, compd. with N’-(4-chlorophenyl)-N,N-dimethylurea (1:1)

140-41-0

Retinoic acid

302-79-4

29-Nordammara-17(20),24-dien-21-oic acid, 16-(acetyloxy)-3,11-dihydroxy-, monosodium salt, (3α,4α,8α,9β,11α,13α,14β,16β,17Z)-

751-94-0

Thorium oxide (ThO2)

1314-20-1

Benzoic acid, 5-[(3-carboxy-5-methyl-4-oxo-2,5-cyclohexadien-1-ylidene)(2,6-dichlorophenyl)methyl]-2-hydroxy-3-methyl-, disodium salt

1796-92-5

9,10-Anthracenedione, 1,4-bis[(4-methoxyphenyl)amino]-

2944-30-1

1H-Indene, 2,3-dihydro-1,1,3-trimethyl-3-phenyl-

3910-35-8

Benzoic acid, 2-[3,6-bis(acetyloxy)-2,7-dichloro-9H-xanthen-9-yl]-

4091-99-0

Cyclohexanone, 2,6-bis[(4-azidophenyl)methylene]-4-methyl-

5284-79-7

Hydrazinecarboxylic acid, [(1,4-dioxido-2-quinoxalinyl)methylene]-, methyl ester

6804-07-5

Benzeneacetic acid, 1-phenyl-1,2-ethanediyl ester

7717-62-6

Mercury iodide (HgI2)

7774-29-0

3,5-Dioxa-6-aza-4-phosphaoct-6-ene-8-nitrile, 4-ethoxy-7-phenyl-, 4-sulfide

14816-18-3

9,10-Anthracenedione, 1-amino-2-[4-[(hexahydro-2-oxo-1H-azepin-1-yl)methyl]phenoxy]-4-hydroxy-

19014-53-0

1,4-Benzenedicarboxylic acid, 2-[[4-(2,2-dicyanoethenyl)-3-methylphenyl]ethylamino]ethyl methyl ester

41284-31-5

Xanthylium, 3,6-bis(diethylamino)-9-[2-(methoxycarbonyl)phenyl]-

47742-71-2

2,4-Oxazolidinedione, 3-(3,5-dichlorophenyl)-5-ethenyl-5-methyl-

50471-44-8

Acetic acid, [4-[(1-amino-9,10-dihydro-4-hydroxy-9,10-dioxo-2-anthracenyl)oxy]phenoxy]-, ethyl ester

52236-80-3

Fatty acids, tall-oil, zinc salts

61790-11-2

Naphthenic acids, compds. with N-tallow alkyltrimethylenediamines

61790-54-3

Benzoxazolium, 3-ethyl-5-phenyl-2-[2-[[3-(3-sulfopropyl)-2(3H)-benzoxazolylidene]methyl]-1-butenyl]-, hydroxide, inner salt

63148-76-5

Naphthalenedisulfonic acid, diisononyl-, compd. with 1,1’-iminobis[2-propanol] (1:2)

63568-35-4

Methanone, [2-hydroxy-4-[2-hydroxy-3-(octyloxy)propoxy]phenyl]phenyl-

68083-40-9

Barium, acetate tallow fatty acids complexes

68201-19-4

Benzoic acid, 2-[[[2,4(*o*r 3,5)-dimethyl-3-cyclohexen-1-yl]methyl]amino]-, ethyl ester

68228-09-1 

Fatty acids, tall oil, compds. with 2-[(2-hydroxyphenyl)methylene]hydrazinecarboximidamide

68334-11-2

Amines, N-(hydrogenated tallow alkyl)trimethylenedi-

68603-64-5

C.I. Pigment Yellow 157

68610-24-2

Pyrethrins and Pyrethroids, manufg.-residues

68648-44-2

Quaternary ammonium compounds, dicoco alkyldimethyl, nitrites

71487-01-9

Benzothiazolium, 5-chloro-2-[[5-[(5-chloro-1,3-diethyl-1,3-dihydro-2H-benzimidazol-2-ylidene)ethylidene]-3-ethyl-4-oxo-2-thiazolidinylidene]methyl]-3-ethyl-, iodide

106068-87-5

Phophinodithioic acid, bis(2,4,4-trimethylpentyl)-

107667-02-7

2-Naphthalenesulfonic acid, 1,5-bis(1-methylethyl)-, compd. with cyclohexanamine (1:1)

132373-76-3

2-Butanone, 4-[[[1,2,3,4,4a,9,10,10a-octahydro-1,4a-dimethyl-7-(1-methylethyl)-1-phenanthrenyl]methyl](3-oxo-3-phenylpropyl)amino]-, hydrochloride, [1R-(1a,4aa)]-

143106-84-7

 

For more information regarding CEPA Chemical Substances, please contact Mark Roehler.